Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma

We have used cDNA arrays to investigate gene expression patterns in peripheral blood mononuclear cells from patients with leukemic forms of cutaneous T cell lymphoma, primarily Sezary syndrome (SS). When expression data for patients with high blood tumor burden (Sezary cells >60% of the lymphocytes) and healthy controls are compared by Student's t test, at P < 0.01, we find 385 genes to be differentially expressed. Highly overexpressed genes include Th2 cells–specific transcription factors Gata-3 and Jun B, as well as integrin β1, proteoglycan 2, the RhoB oncogene, and dual specificity phosphatase 1. Highly underexpressed genes include CD26, Stat-4, and the IL-1 receptors. Message for plastin-T, not normally expressed in lymphoid tissue, is detected only in patient samples and may provide a new marker for diagnosis. Using penalized discriminant analysis, we have identified a panel of eight genes that can distinguish SS in patients with as few as 5% circulating tumor cells. This suggests that, even in early disease, Sezary cells produce chemokines and cytokines that induce an expression profile in the peripheral blood distinctive to SS. Finally, we show that using 10 genes, we can identify a class of patients who will succumb within six months of sampling regardless of their tumor burden.

[1]  J. Downward,et al.  Chemokines Fail to Up-Regulate β1 Integrin-Dependent Adhesion in Human Th2 T Lymphocytes1 , 2000, The Journal of Immunology.

[2]  K. Shigesada,et al.  Human T cell L-plastin bundles actin filaments in a calcium-dependent manner. , 1992, Journal of biochemistry.

[3]  R. Willemze,et al.  DISTINCTIVE ADHESION PATHWAYS ARE INVOLVED IN EPITHELIOTROPIC PROCESSES AT DIFFERENT SITES , 1996, The Journal of pathology.

[4]  J. Schellens,et al.  Ras biochemistry and farnesyl transferase inhibitors: a literature survey , 2001, Anti-cancer drugs.

[5]  K. Rottner,et al.  Functional design in the actin cytoskeleton. , 1999, Current opinion in cell biology.

[6]  A. Rook,et al.  The immunopathogenesis of cutaneous T-cell lymphoma. , 1995, Hematology/oncology clinics of North America.

[7]  M. Arpin,et al.  Functional differences between L- and T-plastin isoforms , 1994, The Journal of cell biology.

[8]  R. Flavell,et al.  Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells. , 1997, Journal of immunology.

[9]  S. Lessin,et al.  Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. , 1994, The Journal of investigative dermatology.

[10]  J. Galon,et al.  Stat4 Is Expressed in Activated Peripheral Blood Monocytes, Dendritic Cells, and Macrophages at Sites of Th1-Mediated Inflammation1 , 2000, The Journal of Immunology.

[11]  W. Macey,et al.  Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. , 1996, Journal of the American Academy of Dermatology.

[12]  G. Trinchieri,et al.  CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .

[13]  T. Lue,et al.  Differential regulation of human T-plastin gene in leukocytes and non-leukocytes: identification of the promoter, enhancer, and CpG island. , 1999, DNA and cell biology.

[14]  A. Ridley Rho Proteins: Linking Signaling with Membrane Trafficking , 2001, Traffic.

[15]  A. Varghese,et al.  Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. , 1999, Archives of dermatology.

[16]  J. Eberwine,et al.  Amplified RNA synthesized from limited quantities of heterogeneous cDNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Whittaker,et al.  Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. , 2003, Blood.

[18]  Yuen Ren Chao,et al.  Human Behavior and the Principle of Least Effort: An Introduction to Human Ecology , 1950 .

[19]  S. Narumiya,et al.  Rho effectors and reorganization of actin cytoskeleton , 1997, FEBS letters.

[20]  J. Guilhou,et al.  Decreased expression of Fas (APO‐1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T‐cell lymphomas , 2000, The British journal of dermatology.

[21]  J. Sedat,et al.  Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. , 2001, Immunity.

[22]  R. Edelson Cutaneous T Cell Lymphoma , 2001, The Journal of dermatologic surgery and oncology.

[23]  Shigemi Kinoshita,et al.  Activation of the PKB/AKT pathway by ICAM-2. , 2002, Immunity.

[24]  M. Edidin,et al.  Selective export of MHC class I molecules from the ER after their dissociation from TAP. , 2000, Immunity.

[25]  J. O’Shea,et al.  Inducible Expression of Stat4 in Dendritic Cells and Macrophages and Its Critical Role in Innate and Adaptive Immune Responses1 , 2001, The Journal of Immunology.

[26]  A. de Matteis,et al.  Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  J. Pober,et al.  Human Endothelial Cell Presentation of Antigen and the Homing of Memory/Effector T Cells to Skin , 2001, Annals of the New York Academy of Sciences.

[28]  R. Tibshirani,et al.  Penalized Discriminant Analysis , 1995 .

[29]  A. Rook,et al.  Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. , 1992, The Journal of investigative dermatology.

[30]  G. Wood,et al.  Cutaneous lymphoid hyperplasias. , 2000, Seminars in cutaneous medicine and surgery.

[31]  L. Showe,et al.  Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. , 1999, Journal of immunology.

[32]  G. Trinchieri,et al.  CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. , 1999, Clinical immunology.

[33]  A. Varghese,et al.  Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome. , 1995, Archives of dermatology.

[34]  G. Prendergast,et al.  Actin' up: RhoB in cancer and apoptosis , 2001, Nature Reviews Cancer.

[35]  G. Trinchieri,et al.  Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10 , 1996, The Journal of experimental medicine.

[36]  R. Flavell,et al.  Regulation of IL‐4 expression by the transcription factor JunB during T helper cell differentiation , 1999, The EMBO journal.

[37]  A. Rao,et al.  Molecular aspects of T-cell differentiation. , 2000, British medical bulletin.

[38]  S. Sebti,et al.  Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues , 2000, Expert opinion on investigational drugs.

[39]  P. Allavena,et al.  Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. , 2001, The Journal of clinical investigation.

[40]  S. Lessin,et al.  Failure to detect human T-lymphotropic virus type-I proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphoma. , 1996, The Journal of investigative dermatology.

[41]  T. Luft,et al.  IL-1β Enhances CD40 Ligand-Mediated Cytokine Secretion by Human Dendritic Cells (DC): A Mechanism for T Cell-Independent DC Activation1 , 2002, The Journal of Immunology.

[42]  R. Feinmesser,et al.  [Kimura's disease and angiolymphoid hyperplasia with eosinophilia-- on disease with different expressions?]. , 1998, Harefuah.

[43]  N. Dang,et al.  Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. , 2001, American journal of clinical pathology.

[44]  S. Lessin,et al.  The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cells. , 1993, Archives of dermatology.

[45]  K. Bacon,et al.  The Chemokine Fractalkine Inhibits Fas-Mediated Cell Death of Brain Microglia , 2000, Journal of Immunology.

[46]  W. Macey,et al.  Photopheresis: clinical applications and mechanism of action. , 1999, The journal of investigative dermatology. Symposium proceedings.

[47]  K. Tashiro,et al.  Versican Interacts with Chemokines and Modulates Cellular Responses* , 2001, The Journal of Biological Chemistry.

[48]  R. Flavell,et al.  Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype. , 1997, Journal of immunology.

[49]  A. Dorner,et al.  Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[50]  R. Strieter,et al.  Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques. , 1994, Clinical immunology and immunopathology.

[51]  David B. Allison,et al.  A mixture model approach for the analysis of microarray gene expression data , 2002 .

[52]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Dummer,et al.  Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). , 1996, Blood.

[54]  R. Edelson Cutaneous T cell lymphoma: the helping hand of dendritic cells. , 2001, Annals of the New York Academy of Sciences.